Obermatt
See Similar Stocks →

Flags

Financial distress

Tevogen Bio Holdings

NMQ:TVGN · US88165K1016
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book69
Dividend Yield1
Revenue Growth—
Profit Growth43
Capital Growth56
TSR 52w1
Leverage6
Liquidity17
Refinancing15
Combined—
Analyst Opinions1
Pro Holdings11
Opinion Changes4
Market Pulse35

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQGM
Employees20
Websitetevogen.com
ISINUS88165K1016
Last UpdateApr 2, 2026
Index & Theme
ImmunologyNeurologyInfectious DiseasesOncologyVaccinesBiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalProduct ResearchTherapeutics

Description

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The company is harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes (‘CTLs’), to develop off-the-shelf, precision T cell therapies…

Similar Stocks

The companies this stock is ranked against.

Compare Tevogen Bio Holdings with its peers
Caribou Biosciences
NSQ:CRBU
39
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Regeneron Pharmaceuticals
NSQ:REGN
83
CountryUSA
IndustryBiotechnology
SizeLarge
Full Stock Analysis →
Precision BioSciences
NAQ:DTIL
39
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Vaxcyte
NSQ:PCVX
54
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nkarta
NSQ:NKTX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Vir Biotechnology
NSQ:VIR
56
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →